More than 130,000 patients participate in 3,000 clinical trials in Spain

Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic power in clinical research in the world. Ahead of countries “like Germany or China” with many more resources, as stressed by the new president of Farmaindustria, Martin Sellés. Currently, […]

Farma-Biotech promotes nine projects on innovative drugs

Source: redaccionmedica.com Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national and international pharmaceutical companies at a conference organized in Madrid by the Farma-Biotech program of Farmaindustria. For this seventeenth call and after a careful study of the needs expressed […]

INCLIVA shows the possible improvement of atherosclerosis through a molecule

Source: actasanitaria.com Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, increases the number of a type of protective cells known as T cells of the cholesterol plate. , which makes it more resistant to artery ruptures, so that “the […]

Novartis works with 50 molecules in the development of new CART therapies

Source: redaccionmedica.com The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of gene therapies. The ABC of CAR-T ‘cellular therapy, a meeting held by Novartis and the Menéndez Pelayo International University (UIMP) at the National School of Health. Personalized medicine is […]

Astra Zeneca presents new indications on the benefits of Brilique

Source: redaccionmedica.com AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings contribute to advance the clinical knowledge of the role of double antiplatelet therapy in the treatment of patients after myocardial infarction (MI) after the first 12 months of treatment […]

EMA publishes a report on the impact of Brexit on the authorization of medicines

Source: actasanitaria.com A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the European Medicines Agency (EMA) has published a report on the meeting of 24 September 2018 that was held with industry stakeholders to discuss the departure of the UK from […]

Europe approves a new indication for Xtandi, from Astellas, for prostate cancer

Source: actasanitaria.com The European Commission has approved a new indication of enzalutamide, a drug whose trade name is Xtandi and which was registered by the pharmaceutical company Astellas Pharma, for the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (CRPCnm). . “Enzalutamide thus becomes one of the first approved treatments for this critical […]

Enhance R & D and protect intellectual property, petitions from the pharmaceutical industry to Europe

Source: actasanitaria.com In order to highlight the priorities of the sector when there are just over seven months left for the next European elections, a manifesto, made public by the European Federation of the Pharmaceutical Industry (EFPIA), in which Farmaindustria is integrated, has collected as requests from the pharmaceutical industry to the future Europe to […]

The AEMPS publishes new features in the treatment of drug registration dossiers

Source: actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the news regarding the submission of requests for regulatory activities of medicines for human use, being mandatory from January 1, 2019 the use of the eCTD format in all applications for authorization, variation and revalidation, both under national (NP) and European (MRP […]

Cataluña allocates 9.5 million to Peris, its health innovation plan

Source: redaccionmedica.com The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation in Health (Peris 2016-2020). This project is one of the axes of the Ministry of Health for planning, momentum and coordination and innovation for the coming years. The objective […]